Michael R. Megna, Chief Accounting Officer at Kiniksa Pharmaceuticals International ($KNSA), sold about $3.8 million in company shares across six open market transactions over the past year. His most recent sale occurred on October 20, 2025. These sales rank 2,316th among over 11,700 insiders in our database, where the average is about $8.6 million per seller over roughly 6.4 trades. Megna made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2644 | $0.00 | 7,931.0000 | 78,979,030 | 25.00% | 0.00% |
| Jan. 15, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Class A Ordinary Share | 372 | $24.16 | 27,418.0000 | 78,979,030 | 1.38% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2362 | $0.00 | 4,725.0000 | 78,979,030 | 33.33% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2558 | $0.00 | 2,557.0000 | 78,979,030 | 50.01% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Performance Share Unit | 7300 | $0.00 | 7,300.0000 | 78,979,030 | 9999.99% | 0.01% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Restricted Share Unit | 3650 | $0.00 | 3,650.0000 | 78,979,030 | 9999.99% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Share Option | 14600 | $0.00 | 14,600.0000 | 78,979,030 | 9999.99% | 0.02% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 3205 | $48.13 | 31,777.0000 | 78,979,030 | 9.16% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 7564 | $0.00 | 34,982.0000 | 78,979,030 | 27.59% | 0.01% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 13235 | $39.31 | 27,046.0000 | 80,035,400 | 32.86% | 0.02% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 791 | $15.50 | 38,892.0000 | 80,035,400 | 2.08% | 0.00% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 6195 | $12.97 | 45,087.0000 | 80,035,400 | 15.93% | 0.01% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 9831 | $11.10 | 54,918.0000 | 80,035,400 | 21.80% | 0.01% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 9831 | $11.97 | 64,749.0000 | 80,035,400 | 17.90% | 0.01% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 12787 | $10.76 | 77,536.0000 | 80,035,400 | 19.75% | 0.02% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 37255 | $38.72 | 40,281.0000 | 80,035,400 | 48.05% | 0.05% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 791 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.00% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 6195 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.01% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 9831 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.01% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 9831 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.01% |
| Oct. 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 12787 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.02% |
| Oct. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 85 | $38.49 | 38,101.0000 | 80,035,400 | 0.22% | 0.00% |
| Oct. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 175 | $0.00 | 38,186.0000 | 80,035,400 | 0.46% | 0.00% |
| Oct. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 175 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 774 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 2557 | $0.00 | 37,961.0000 | 77,942,082 | 7.22% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 2363 | $0.00 | 35,404.0000 | 77,942,082 | 7.15% | 0.00% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 11000 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.01% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Restricted Share Unit | 10575 | $0.00 | 10,575.0000 | 77,942,082 | 9999.99% | 0.01% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 11000 | $34.84 | 38,011.0000 | 77,942,082 | 22.44% | 0.01% |
| Sept. 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 11000 | $17.92 | 49,011.0000 | 77,942,082 | 28.94% | 0.01% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 375 | $34.28 | 38,011.0000 | 77,942,082 | 0.98% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 774 | $0.00 | 38,386.0000 | 77,942,082 | 2.06% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 4282 | $33.49 | 37,612.0000 | 77,942,082 | 10.22% | 0.01% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 3933 | $0.00 | 41,894.0000 | 77,942,082 | 10.36% | 0.01% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Share Option | 21150 | $0.00 | 21,150.0000 | 77,942,082 | 9999.99% | 0.03% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2363 | $0.00 | 7,087.0000 | 77,942,082 | 25.01% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2557 | $0.00 | 5,115.0000 | 77,942,082 | 33.33% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 3933 | $0.00 | 3,932.0000 | 77,942,082 | 50.01% | 0.01% |
| July 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Class A Ordinary Share | 495 | $15.63 | 33,041.0000 | 77,942,082 | 1.52% | 0.00% |
| Aug. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 17000 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.02% |
| Aug. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 17000 | $32.35 | 33,041.0000 | 77,942,082 | 33.97% | 0.02% |
| Aug. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 17000 | $15.52 | 50,041.0000 | 77,942,082 | 51.45% | 0.02% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 15211 | $15.50 | 47,757.0000 | 76,145,617 | 46.74% | 0.02% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 15211 | $0.00 | 791.0000 | 76,145,617 | 95.06% | 0.02% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 15211 | $28.75 | 32,546.0000 | 76,145,617 | 31.85% | 0.02% |
| May 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 17647 | $26.69 | 32,546.0000 | 76,145,617 | 35.16% | 0.02% |
| May 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 229 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.00% |
| May 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 2998 | $0.00 | 16,002.0000 | 76,145,617 | 15.78% | 0.00% |
| May 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 14420 | $0.00 | 17,040.0000 | 76,145,617 | 45.84% | 0.02% |
| May 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 229 | $8.83 | 32,775.0000 | 76,145,617 | 0.70% | 0.00% |
| May 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 2998 | $15.50 | 35,773.0000 | 76,145,617 | 9.15% | 0.00% |
| May 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 14420 | $11.97 | 50,193.0000 | 76,145,617 | 40.31% | 0.02% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Performance Share Option | 5456 | $0.00 | 5,456.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Performance Share Option | 5285 | $0.00 | 5,285.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Performance Share Unit | 3433 | $0.00 | 3,433.0000 | 76,145,617 | 9999.99% | 0.00% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Performance Share Unit | 3270 | $0.00 | 3,270.0000 | 76,145,617 | 9999.99% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 3933 | $0.00 | 3,932.0000 | 76,145,617 | 50.01% | 0.01% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 3933 | $0.00 | 34,212.0000 | 76,145,617 | 12.99% | 0.01% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 1666 | $20.28 | 32,546.0000 | 76,145,617 | 4.87% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Share Option | 21150 | $0.00 | 21,150.0000 | 76,145,617 | 9999.99% | 0.03% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 2557 | $0.00 | 30,000.0000 | 76,145,617 | 9.32% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 2363 | $0.00 | 32,363.0000 | 76,145,617 | 7.88% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 1083 | $21.77 | 31,280.0000 | 76,145,617 | 3.35% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 1001 | $21.77 | 30,279.0000 | 76,145,617 | 3.20% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Restricted Share Unit | 10575 | $0.00 | 10,575.0000 | 76,145,617 | 9999.99% | 0.01% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2557 | $0.00 | 5,115.0000 | 76,145,617 | 33.33% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2363 | $0.00 | 7,087.0000 | 76,145,617 | 25.01% | 0.00% |
| Jan. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Class A Ordinary Share | 469 | $16.00 | 26,997.0000 | 71,424,159 | 1.77% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 774 | $0.00 | 0.0000 | 71,424,159 | 100.00% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 328 | $22.61 | 27,443.0000 | 71,424,159 | 1.18% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 774 | $0.00 | 27,771.0000 | 71,424,159 | 2.87% | 0.00% |
| March 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 9051 | $22.45 | 26,528.0000 | 71,424,159 | 25.44% | 0.01% |
| March 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 9051 | $0.00 | 13,763.0000 | 71,424,159 | 39.67% | 0.01% |
| March 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 9051 | $11.10 | 35,579.0000 | 71,424,159 | 34.12% | 0.01% |
| Nov. 27, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 8637 | $22.45 | 26,528.0000 | 71,726,685 | 24.56% | 0.01% |
| Nov. 29, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 9 | $11.10 | 26,537.0000 | 71,726,685 | 0.03% | 0.00% |
| Nov. 29, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Ordinary Share | 9 | $22.45 | 26,528.0000 | 71,726,685 | 0.03% | 0.00% |
| Nov. 27, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 8637 | $0.00 | 22,823.0000 | 71,726,685 | 27.45% | 0.01% |
| Nov. 29, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 9 | $0.00 | 22,814.0000 | 71,726,685 | 0.04% | 0.00% |
| Nov. 27, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 8637 | $11.10 | 35,165.0000 | 71,726,685 | 32.56% | 0.01% |
| Oct. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 175 | $0.00 | 26,610.0000 | 71,726,685 | 0.66% | 0.00% |
| Oct. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 175 | $0.00 | 175.0000 | 71,726,685 | 50.00% | 0.00% |
| Oct. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 82 | $24.48 | 26,528.0000 | 71,726,685 | 0.31% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2558 | $0.00 | 7,672.0000 | 71,004,640 | 25.00% | 0.00% |
| July 15, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Class A Ordinary Share | 480 | $15.65 | 22,254.0000 | 71,004,640 | 2.20% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 6490 | $0.00 | 28,744.0000 | 71,004,640 | 29.16% | 0.01% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 2755 | $26.74 | 25,989.0000 | 71,004,640 | 9.58% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Ordinary Share | 775 | $0.00 | 26,764.0000 | 71,004,640 | 2.98% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Ordinary Share | 329 | $26.74 | 26,435.0000 | 71,004,640 | 1.23% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Restricted Share Unit | 9450 | $0.00 | 9,450.0000 | 71,004,640 | 9999.99% | 0.01% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Share Option | 18900 | $0.00 | 18,900.0000 | 71,004,640 | 9999.99% | 0.03% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 3932 | $0.00 | 7,865.0000 | 71,004,640 | 33.33% | 0.01% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 775 | $0.00 | 774.0000 | 71,004,640 | 50.03% | 0.00% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 1666 | $17.90 | 21,328.0000 | 70,633,023 | 7.25% | 0.00% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 3932 | $0.00 | 22,994.0000 | 70,633,023 | 20.63% | 0.01% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Share Option | 18900 | $0.00 | 18,900.0000 | 70,633,023 | 9999.99% | 0.03% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Restricted Share Unit | 9450 | $0.00 | 17,122.0000 | 70,633,023 | 123.18% | 0.01% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 3932 | $0.00 | 13,190.0000 | 70,633,023 | 22.96% | 0.01% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 2558 | $0.00 | 20,146.0000 | 70,633,023 | 14.54% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 1084 | $19.70 | 19,062.0000 | 70,633,023 | 5.38% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2558 | $0.00 | 7,672.0000 | 70,633,023 | 25.00% | 0.00% |
| Feb. 28, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 5126 | $8.83 | 22,714.0000 | 71,922,915 | 29.14% | 0.01% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 4014 | $0.00 | 0.0000 | 71,922,915 | 100.00% | 0.01% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 5645 | $0.00 | 229.0000 | 71,922,915 | 96.10% | 0.01% |
| Feb. 28, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 5126 | $0.00 | 5,874.0000 | 71,922,915 | 46.60% | 0.01% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Common Share | 9659 | $21.45 | 17,588.0000 | 71,922,915 | 35.45% | 0.01% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 4014 | $13.88 | 27,247.0000 | 71,922,915 | 17.28% | 0.01% |
| March 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 5645 | $8.83 | 23,233.0000 | 71,922,915 | 32.10% | 0.01% |
| Feb. 28, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Common Share | 5126 | $21.79 | 17,588.0000 | 71,922,915 | 22.57% | 0.01% |
| Jan. 15, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Class A Common Share | 583 | $12.35 | 17,588.0000 | 71,922,915 | 3.43% | 0.00% |
| Jan. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 16670 | $13.88 | 33,675.0000 | 71,922,915 | 98.03% | 0.02% |
| Jan. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Common Share | 16670 | $19.17 | 17,005.0000 | 71,922,915 | 49.50% | 0.02% |
| Jan. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 16670 | $0.00 | 4,014.0000 | 71,922,915 | 80.59% | 0.02% |
| Dec. 19, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S | Class A Common Share | 9316 | $19.13 | 17,005.0000 | 70,186,016 | 35.39% | 0.01% |
| Dec. 19, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 9316 | $13.88 | 26,321.0000 | 70,186,016 | 54.78% | 0.01% |
| Dec. 19, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Share Option | 9316 | $0.00 | 20,684.0000 | 70,186,016 | 31.05% | 0.01% |
| Oct. 4, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 175 | $0.00 | 17,057.0000 | 70,186,016 | 1.04% | 0.00% |
| Oct. 4, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 52 | $16.01 | 17,005.0000 | 70,186,016 | 0.30% | 0.00% |
| Oct. 4, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 175 | $0.00 | 350.0000 | 70,186,016 | 33.33% | 0.00% |
| July 15, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Class A Common Share | 581 | $12.35 | 13,558.0000 | 71,634,729 | 4.48% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 3933 | $0.00 | 17,491.0000 | 71,634,729 | 29.01% | 0.01% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 1155 | $17.76 | 16,336.0000 | 71,634,729 | 6.60% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 774 | $0.00 | 17,110.0000 | 71,634,729 | 4.74% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 228 | $17.76 | 16,882.0000 | 71,634,729 | 1.33% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 3933 | $0.00 | 11,797.0000 | 71,634,729 | 25.00% | 0.01% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Restricted Share Unit | 10230 | $0.00 | 10,230.0000 | 71,634,729 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Share Option | 20459 | $0.00 | 20,459.0000 | 71,634,729 | 9999.99% | 0.03% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 774 | $0.00 | 1,549.0000 | 71,634,729 | 33.32% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 3933 | $0.00 | 11,797.0000 | 69,751,697 | 50.01% | 0.01% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 1155 | $10.71 | 12,977.0000 | 69,751,697 | 8.17% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 3933 | $0.00 | 14,132.0000 | 69,751,697 | 38.56% | 0.01% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Restricted Share Unit | 10230 | $0.00 | 10,230.0000 | 69,751,697 | 9999.99% | 0.01% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Share Option | 20459 | $0.00 | 20,459.0000 | 69,751,697 | 9999.99% | 0.03% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 774 | $0.00 | 8,892.0000 | 70,421,322 | 9.53% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 635 | $11.12 | 10,199.0000 | 70,421,322 | 5.86% | 0.00% |
| Jan. 15, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | A | Class A Common Share | 704 | $9.56 | 8,118.0000 | 70,421,322 | 9.50% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 774 | $0.00 | 1,549.0000 | 70,421,322 | 33.32% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Restricted Share Unit | 2163 | $0.00 | 0.0000 | 70,421,322 | 100.00% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | M | Class A Common Share | 2163 | $0.00 | 10,834.0000 | 70,421,322 | 24.95% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | F | Class A Common Share | 221 | $11.46 | 8,671.0000 | 70,421,322 | 2.49% | 0.00% |